Newsfeeds Archive - Page 4 of 211

1 minute read

Heart Test Laboratories Q3 EPS $(0.16) Beats $(0.22) Estimate, Sales $1.95K

March 16, 4:32 PM

Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.22) by 27.27 percent. The company reported $1.95 thousand in sales this quarter.

HSCS

1 minute read

ATI Physical Therapy Q4 Sales $161.76M Miss $162.66M Estimate

By Michael Horton

March 16, 4:27 PM

ATI Physical Therapy (NYSE:ATIP) reported quarterly sales of $161.76 million which missed the analyst consensus estimate of $162.66 million by 0.55 percent. This is a 3.85 percent increase over sales of $155.76 million

ATIP

1 minute read

RiceBran Tech Q4 EPS $(0.28) Up From $(1.00) YoY, Sales $10.62M Beat $8.59M Estimate

By Michael Horton

March 16, 4:21 PM

RiceBran Tech (NASDAQ:RIBT) reported quarterly losses of $(0.28) per share. This is a 72 percent increase over losses of $(1.00) per share from the same period last year. The company reported quarterly sales of $10.62

RIBT

1 minute read

Achieve Life Sciences Q4 EPS $(0.83), Inline

By Michael Horton

March 16, 4:20 PM

Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.83) per share which met the analyst consensus estimate. This is a 9.21 percent decrease over losses of $(0.76) per share from the same period last

ACHV

1 minute read

Karat Packaging Q4 Adj. EPS $0.30 Misses $0.32 Estimate, Sales $92.67M Miss $96.12M Estimate

By Michael Horton

March 16, 4:18 PM

Karat Packaging (NASDAQ:KRT) reported quarterly earnings of $0.30 per share which missed the analyst consensus estimate of $0.32 by 6.25 percent. This is a 6.25 percent decrease over earnings of $0.32 per share from the

KRT

1 minute read

Blend Labs Q4 Adj. EPS $(0.21) Misses $(0.16) Estimate, Sales $42.78M Miss $44.92M Estimate

By Michael Horton

March 16, 4:10 PM

Blend Labs (NYSE:BLND) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.16) by 31.25 percent. This is a 10.53 percent decrease over losses of $(0.19) per share from the

BLND

1 minute read

BioLife Solutions Q4 Sales $44.26M Beat $43.28M Estimate

By Michael Horton

March 16, 4:06 PM

BioLife Solutions (NASDAQ:BLFS) reported quarterly sales of $44.26 million which beat the analyst consensus estimate of $43.28 million by 2.26 percent. This is a 18.64 percent increase over sales of $37.30 million the

BLFS